DLB vs IPGP

For growth investors, Dolby Laboratories, Inc.

(DLB) is the stronger pick with 5. 9% revenue growth year-over-year, versus 2. 7% for IPG Photonics Corporation (IPGP). Dolby Laboratories, Inc. (DLB) offers the better valuation at 22. 1x trailing P/E (13. 4x forward), making it the more compelling value choice. Analysts rate Dolby Laboratories, Inc. (DLB) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Dolby Laboratories, Inc.

(DLB) is the cheapest at 22. 1x versus IPG Photonics Corporation at 139. 6x. On forward P/E, Dolby Laboratories, Inc. is actually cheaper at 13. 4x.

Over the past 5 years, Dolby Laboratories, Inc.

(DLB) delivered a total return of -34. 2%, compared to -48. 3% for IPG Photonics Corporation (IPGP). Over 10 years, the gap is even starker: DLB returned +48. 0% versus IPGP's +21. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Dolby Laboratories, Inc.

(DLB) is the lower-risk stock at 0. 82β versus IPG Photonics Corporation's 1. 80β — meaning IPGP is approximately 118% more volatile than DLB relative to the S&P 500.

By revenue growth (latest reported year), Dolby Laboratories, Inc.

(DLB) is pulling ahead at 5. 9% versus 2. 7% for IPG Photonics Corporation (IPGP). On earnings-per-share growth, the picture is similar: IPG Photonics Corporation grew EPS 117. 8% year-over-year, compared to -2. 6% for Dolby Laboratories, Inc.. Over a 3-year CAGR, DLB leads at 2. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Dolby Laboratories, Inc.

(DLB) is the more profitable company, earning 18. 9% net margin versus 3. 1% for IPG Photonics Corporation — meaning it keeps 18. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DLB leads at 19. 6% versus 1. 3% for IPGP. At the gross margin level — before operating expenses — DLB leads at 88. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Dolby Laboratories, Inc.

(DLB) trades at 13. 4x forward P/E versus 62. 8x for IPG Photonics Corporation — 49. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IPGP: 48. 8% to $151. 67.

In this comparison, DLB (2.

2% yield) pays a dividend. IPGP does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Dolby Laboratories, Inc.

(DLB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 82), 2. 2% yield). IPG Photonics Corporation (IPGP) carries a higher beta of 1. 80 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DLB: +48. 0%, IPGP: +21. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

DLB pays a dividend while IPGP does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.